SEDALMEX Trademark

Trademark Overview


On Thursday, November 29, 2018, a trademark application was filed for SEDALMEX with the United States Patent and Trademark Office. The USPTO has given the SEDALMEX trademark a serial number of 88210495. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2019. This trademark is owned by Integrated Pharma Solutions. The SEDALMEX trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics
sedalmex

General Information


Serial Number88210495
Word MarkSEDALMEX
Filing DateThursday, November 29, 2018
Status700 - REGISTERED
Status DateTuesday, October 1, 2019
Registration Number5871605
Registration DateTuesday, October 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2019

Trademark Statements


Goods and ServicesAnalgesics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 17, 2018
Primary Code005
First Use Anywhere DateMonday, November 12, 2018
First Use In Commerce DateMonday, November 12, 2018

Trademark Owner History


Party NameIPS TRUST
Party Type31 - New Owner After Registration
Legal Entity Type17 - Trust
AddressARLINGTON, VA 22201

Party NameIntegrated Pharma Solutions
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressArlington, VA 22201

Party NameIntegrated Pharma Solutions
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressArlington, VA 22202

Party NameIntegrated Pharma Solutions
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressArlington, VA 22202

Trademark Events


Event DateEvent Description
Saturday, March 2, 2019NON-FINAL ACTION WRITTEN
Monday, December 3, 2018NEW APPLICATION ENTERED
Monday, December 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 28, 2019ASSIGNED TO EXAMINER
Saturday, March 2, 2019NON-FINAL ACTION E-MAILED
Saturday, March 2, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 13, 2019ASSIGNED TO LIE
Wednesday, March 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 26, 2019WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Tuesday, May 21, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, May 21, 2019NON-FINAL ACTION WRITTEN
Tuesday, May 21, 2019NON-FINAL ACTION E-MAILED
Tuesday, May 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, March 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 16, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords


sedalmex analgesics